AAC
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hatabu, T.
Right arrow Articles by Kano, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hatabu, T.
Right arrow Articles by Kano, S.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, February 2005, p. 493-496, Vol. 49, No. 2
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.2.493-496.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Potent Plasmodicidal Activity of a Heat-Induced Reformulation of Deoxycholate-Amphotericin B (Fungizone) against Plasmodium falciparum

Toshimitsu Hatabu,1* Tsuyoshi Takada,1 Nao Taguchi,1 Mamoru Suzuki,2 Kumiko Sato,1 and Shigeyuki Kano3

Gunma University School of Health Sciences,1 Department of Parasitology, Gunma University School of Medicine, Showa-machi, Maebashi,2 Research Institute, International Medical Center of Japan, Toyama, Shinjyuku-ku, Tokyo, Japan3

Received 29 June 2004/ Returned for modification 9 July 2004/ Accepted 6 October 2004

The emergence and spread of drug-resistant Plasmodium falciparum continue to pose problems in malaria chemotherapy. Therefore, it is necessary to identify new antimalarial drugs and therapeutic strategies. In the present study, the activity of a heat-treated form of amphotericin B (HT-AMB) against P. falciparum was evaluated. The efficacy and toxicity of HT-AMB were also compared with those of the standard formulation (AMB). HT-AMB showed significant activity against a chloroquine-resistant strain (strain K-1) and a chloroquine-susceptible strain (strain FCR-3) in vitro. The 50% inhibitory concentrations of HT-AMB were 0.32 ± 0.03 µg/ml for strain K-1 and 0.33 ± 0.03 µg/ml for strain FCR-3. In the presence of 1.0 µg of HT-AMB per ml, only pyknotic parasites were observed after 24 h of incubation of early trophozoites (ring forms). However, when late trophozoites and schizonts were cultured with 1.0 µg of HT-AMB per ml, those forms multiplied to ring forms but the number of infected erythrocytes did not increase. These results indicate that HT-AMB possesses potent antiplasmodial activity and that the drug is more effective against the ring-form stage than against the late trophozoite and schizont stages. HT-AMB was observed to have little cytotoxic effect against a human liver cell line (Chang liver cells). In conclusion, the results suggest that HT-AMB has promising properties and merits further in vivo investigations as a treatment for falciparum malaria.


* Corresponding author. Mailing address: Gunma University School of Health Sciences, 3-39-15 Showa-machi, Maebashi 371-8514, Japan. Phone: 81-27-220-7111, ext. 8960. Fax: 81-27-220-8915. E-mail: hatabu{at}health.gunma-u.ac.jp.


Antimicrobial Agents and Chemotherapy, February 2005, p. 493-496, Vol. 49, No. 2
0066-4804/05/$08.00+0     doi:10.1128/AAC.49.2.493-496.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Clin. Vaccine Immunol. Clin. Microbiol. Rev.
J. Clin. Microbiol. ALL ASM JOURNALS

Copyright © 2005 by the American Society for Microbiology. All rights reserved.